Decision Support · Side-by-side
Compare pricing, strengths, and use cases so it is easier to pick the right fit.
Change tools
For everyday users, neither Lunit nor Niramai is a consumer tool—they are enterprise medical devices. Lunit wins for large hospitals needing FDA-cleared lung and breast cancer detection from X-rays and mammograms, while Niramai wins for clinics and mobile health programs wanting a radiation-free, portable breast cancer screening option. The single biggest difference: Lunit works with existing hospital imaging systems (PACS), whereas Niramai uses a standalone thermal camera that can be used anywhere.
Lunit
Niramai
Scores at a glance
Choose Lunit if
Choose Niramai if
Key differences
Facts side by side
| Lunit | Niramai | |
|---|---|---|
| Free plan | ||
| Mobile app | ||
| API access |
Common questions
No. Both are enterprise medical devices for hospitals and clinics. You cannot download them as an app or use them at home.
For breast cancer specifically, Niramai is more practical because it's portable, radiation-free, and works on all breast densities. Lunit is better if you already have a mammography machine and want AI to analyze those images.
Niramai is FDA-cleared as an adjunct test, meaning it's meant to be used alongside mammography, not replace it. It has high accuracy but is not a standalone replacement.
Setup involves 10 steps including clinical consultation, infrastructure audit, and staff training. Expect several weeks to months before it's fully operational.
Niramai is likely more affordable for a small clinic because it doesn't require expensive existing imaging equipment. Lunit's pricing is opaque and aimed at large hospitals.
Lunit is for big hospitals with existing imaging gear; Niramai is for clinics wanting portable, radiation-free breast cancer screening.
If you're a non-technical person running a clinic or health program, start with Niramai—it's simpler, portable, and safer for patients. If you're part of a large hospital with a full radiology department, Lunit is the stronger choice for catching lung and breast cancers from existing scans. Neither is for personal use.
